The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Varian Medical Systems Inc

NYSE: VAR
Last

(U.S.) $104.40

Today's change+0.20 +0.19%
Updated October 18 4:02 PM EDT. Delayed by at least 15 minutes.
 

Varian Medical Systems Inc

NYSE: VAR
Last

(U.S.) $104.40

Today's change+0.20 +0.19%
Updated October 18 4:02 PM EDT. Delayed by at least 15 minutes.

Varian Medical Systems Inc up (U.S.)$0.20

Varian Medical Systems Inc closed up Wednesday by (U.S.)$0.20 or 0.19% to (U.S.)$104.40. Over the last five days, shares have gained 3.46% and are currently 3.22% off of the 52-week high. Shares have underperformed the S&P 500 by 11.39% during the last year.

Key company metrics

  • Open(U.S.) $104.46
  • Previous close(U.S.) $104.20
  • High(U.S.) $105.36
  • Low(U.S.) $104.36
  • Bid / Ask(U.S.) $104.00 / (U.S.) $150.00
  • YTD % change+16.28%
  • Volume582,358
  • Average volume (10-day)755,665
  • Average volume (1-month)741,870
  • Average volume (3-month)776,409
  • 52-week range(U.S.) $76.94 to (U.S.) $107.87
  • Beta0.64
  • Trailing P/E33.55×
  • P/E 1 year forward26.81×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.11
Updated October 18 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.28%

Based on its net profit margin of 10.28%, Varian Medical Systems Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.22%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 30, 201612/30/2016Sep 30, 201609/30/2016
Revenue662655612912
Total other revenue--------
Total revenue662655612912
Gross profit293275276388
Total cost of revenue369380336525
Total operating expense546565586743
Selling / general / administrative132140147133
Research & development55535066
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)003817
Other operating expenses, total--------
Operating income1169026170
Interest income (expense), net non-operating-3-2-3-3
Gain (loss) on sale of assets--------
Other--------
Income before tax1179028171
Income after tax916915118
Income tax, total26211453
Net income905620118
Total adjustments to net income--------
Net income before extra. items906914118
Minority interest00-10
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items906914118
Inc. avail. to common incl. extra. items905620118
Diluted net income905620118
Dilution adjustment0----0
Diluted weighted average shares92949494
Diluted EPS excluding extraordinary itemsvalue per share0.980.740.151.24
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.980.740.361.37